|
Market Closed -
Hong Kong S.E.
01:38:17 13/11/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 0.4900 HKD | 0.00% |
|
+2.08% | -2.00% |
| 28/08 | Mabpharm Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 24/06 | Mabpharm Limited Receives Approval for New Drug Application of CMAB807X (Denosumab Injection) | CI |
| Market Cap | 171.93Cr 202.08Cr 26Cr 23Cr 22Cr 19Cr 37Cr 2.43TCr 38Cr 259.35Cr 102.84Cr 1.3TCr 97Cr 95Cr 4.12TCr | P/E 2024 |
-8.48x | P/E 2025 | 44.9x |
|---|---|---|---|---|---|
| Enterprise Value | 193.68Cr 227.64Cr 29Cr 26Cr 24Cr 22Cr 41Cr 2.74TCr 43Cr 292.15Cr 115.84Cr 1.46TCr 108.89Cr 106.58Cr 4.64TCr | EV / Sales 2024 |
5.06x | EV / Sales 2025 | 3.2x |
| Free-Float |
22.82% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +2.08% | ||
| Current month | +12.64% | ||
| 1 month | -2.00% | ||
| 3 months | +16.67% | ||
| 6 months | +2.08% | ||
| Current year | -2.00% |
| 1 week | 0.42 |  | 0.51 |
| 1 month | 0.42 | | 0.55 |
| Current year | 0.31 | | 0.81 |
| 1 year | 0.31 | | 0.81 |
| 3 years | 0.25 | | 0.94 |
| 5 years | 0.25 | | 1.2 |
| 10 years | 0.25 | | 1.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Wang
CEO | Chief Executive Officer | 57 | 28/10/2020 |
Sheng Hou
PRN | Corporate Officer/Principal | 49 | 01/12/2023 |
Jing Tao
PRN | Corporate Officer/Principal | 53 | 03/08/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Hao Wang
BRD | Director/Board Member | 57 | 20/07/2018 |
Yun Feng Li
BRD | Director/Board Member | 49 | 20/07/2018 |
Shu Ge Jiao
CHM | Chairman | 60 | 20/07/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/02/23 | Other | Director | 75,192 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +2.08% | -5.77% | -5.77% | 26Cr | |
| -2.69% | -0.48% | +51.67% | +69.09% | 6.85TCr | |
| -0.92% | +7.67% | +14.26% | +90.92% | 6.13TCr | |
| 0.00% | +0.39% | +20.52% | +98.45% | 5.57TCr | |
| +0.14% | +2.35% | +13.08% | +109.47% | 4.75TCr | |
| -2.21% | -2.47% | +18.60% | +36.89% | 4.47TCr | |
| -2.30% | -10.40% | +167.61% | +776.79% | 3.81TCr | |
| +2.15% | +1.42% | +15.17% | +56.49% | 3.59TCr | |
| -2.32% | -2.24% | +75.52% | +52.70% | 3.31TCr | |
| +2.62% | +5.90% | -36.55% | +406.95% | 2.59TCr | |
| Average | -0.55% | +2.28% | +33.41% | +169.20% | 4TCr | |
| Weighted average by Cap. | -0.86% | +2.09% | +37.70% | +162.03% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 26Cr 30Cr 3.87Cr 3.51Cr 3.24Cr 2.93Cr 5.51Cr 364.76Cr 5.71Cr 39Cr 15Cr 194.85Cr 15Cr 14Cr 618.5Cr | 65Cr 76Cr 9.68Cr 8.77Cr 8.11Cr 7.32Cr 14Cr 912.64Cr 14Cr 97Cr 39Cr 487.51Cr 36Cr 36Cr 1.55TCr |
| Net income | -13Cr -15Cr -1.92Cr -1.74Cr -1.61Cr -1.45Cr -2.73Cr -180.73Cr -2.83Cr -19Cr -7.65Cr -97Cr -7.19Cr -7.04Cr -306.45Cr | 5.71Cr 6.72Cr 85.59L 77.56L 71.74L 64.73L 1.22Cr 81Cr 1.26Cr 8.62Cr 3.42Cr 43Cr 3.21Cr 3.14Cr 136.84Cr |
| Net Debt | 22Cr 26Cr 3.33Cr 3.02Cr 2.79Cr 2.52Cr 4.75Cr 313.93Cr 4.91Cr 34Cr 13Cr 167.7Cr 12Cr 12Cr 532.32Cr | 22Cr 26Cr 3.26Cr 2.95Cr 2.73Cr 2.46Cr 4.64Cr 307.2Cr 4.81Cr 33Cr 13Cr 164.1Cr 12Cr 12Cr 520.9Cr |
Employees
394
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | HK$0.4900 | 0.00% | 0 |
| 12/26/12 | HK$0.4900 | +11.36% | 22,000 |
| 11/26/11 | HK$0.4400 | 0.00% | 2,000 |
| 10/26/10 | HK$0.4400 | -8.33% | 26,000 |
| 09/26/09 | HK$0.4800 | 0.00% | 0 |
- Stock Market
- Stocks
- 2181 Stock
Select your edition
All financial news and data tailored to specific country editions
